Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Frontiers | Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
RTI International's JDTic Helps Scientists Uncover Structure of the Kappa Opioid Receptor | RTI
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor - ScienceDirect
Opioid Receptor | kappa, mu Opioid Receptor
Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved In Vivo Antinociceptive Effect after Peripheral Administration | ACS Medicinal Chemistry Letters
RCSB PDB - 8DZR: GR89,696 bound Kappa Opioid Receptor in complex with gustducin
Structure of opioid receptors may reveal how | EurekAlert!
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Study targets kappa opioid receptor to develop more effective drugs for pain management | Anesthesiology | Washington University School of Medicine in St. Louis
Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor | Journal of Medicinal Chemistry
RCSB PDB - 4DJH: Structure of the human kappa opioid receptor in complex with JDTic
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Ligand and G-protein selectivity in the κ-opioid receptor | Nature
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
RCSB PDB - 6B73: Crystal Structure of a nanobody-stabilized active state of the kappa-opioid receptor